These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 6761633)
1. The pathobiology of lymphocyte transformation. Taylor CR Pathobiol Annu; 1982; 12():65-84. PubMed ID: 6761633 [No Abstract] [Full Text] [Related]
2. [A lymphoproliferative disorder of T-cell origin with appearances of chronic lymphatic leukemia]. Thoden van Velzen AH; Bom-van Noorloos AA; Feltkamp-Vroom TM; von dem Borne AE; Melief CJ; Silberbusch J Ned Tijdschr Geneeskd; 1979 Dec; 123(51):2172-7. PubMed ID: 317509 [No Abstract] [Full Text] [Related]
3. T-cell lymphomas and leukemias of post-thymic differentiation. Kadin ME; Said J Clin Lab Med; 1988 Mar; 8(1):135-50. PubMed ID: 2896086 [TBL] [Abstract][Full Text] [Related]
4. Detection of T and B cell populations in some lymphoproliferative disorders. Herzog P; Stöckbauer P Czech Med; 1980; 3(4):263-70. PubMed ID: 6971744 [TBL] [Abstract][Full Text] [Related]
5. Anaplastic large cell lymphoma and acquired angioedema: a novel association? Rossi D; Gaidano G Ann Ital Med Int; 2002; 17(3):143-5. PubMed ID: 12402660 [No Abstract] [Full Text] [Related]
6. [Benign and malignant lymphoproliferative processes associated with the murine islet system]. Freytag G; Kolb-Bachofen V; Kiesel U; Kolb H Verh Dtsch Ges Pathol; 1981; 65():255-61. PubMed ID: 6750953 [No Abstract] [Full Text] [Related]
7. [Spectrum of lymphoproliferative diseases]. Franssila K Duodecim; 1989; 105(11):1016-39. PubMed ID: 2666087 [No Abstract] [Full Text] [Related]
8. [Surface markers and clinico-pathological characteristics of lymphoproliferative malignancies (author's transl)]. Minato K; Shimoyama M Rinsho Byori; 1978; 26(3):194-200. PubMed ID: 306459 [No Abstract] [Full Text] [Related]
9. [Clinical manifestations of lymphoproliferative disorders of thymic origin]. Pintado Cros T Sangre (Barc); 1984; 29(4-C):731-40. PubMed ID: 6240122 [No Abstract] [Full Text] [Related]
11. [Double-marker (T + B) lymphocytes in lymphoproliferative diseases]. Pecze K; Dalmi L; Rák K Orv Hetil; 1982 Jun; 123(26):1595-7. PubMed ID: 6981087 [No Abstract] [Full Text] [Related]
12. Primary cutaneous lymphoproliferative disorders with dual lineage rearrangement. Kazakov DV; Kutzner H; Palmedo G; Boudova L; Michaelis S; Michal M; Vanecek T; Magro CM; Mukensnabl P; Dummer R; Burg G; Kempf W Am J Dermatopathol; 2006 Oct; 28(5):399-409. PubMed ID: 17012914 [TBL] [Abstract][Full Text] [Related]
13. [Analyses of the rearrangement of T-cell receptor- and immunoglobulin genes in the diagnosis of lymphoproliferative disorders]. Griesser DH Veroff Pathol; 1995; 144():1-109. PubMed ID: 7856305 [TBL] [Abstract][Full Text] [Related]
18. [Typification of the immunoproliferative syndromes]. Leoni P Minerva Med; 1982 Apr; 73(15):911-4. PubMed ID: 6281685 [No Abstract] [Full Text] [Related]
19. Different levels of CD52 antigen expression evaluated by quantitative fluorescence cytometry are detected on B-lymphocytes, CD 34+ cells and tumor cells of patients with chronic B-cell lymphoproliferative diseases. Klabusay M; Sukova V; Coupek P; Brychtova Y; Mayer J Cytometry B Clin Cytom; 2007 Sep; 72(5):363-70. PubMed ID: 17428002 [TBL] [Abstract][Full Text] [Related]